Letters to the Editor

A novel Colony Stimulating Factor 3 Receptor activating mutation identified in a patient with chronic neutrophilic leukemia

Knight Cancer Institute, Division of Oncologic Sciences, Oregon Health and Science University, Portland, OR
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Dana-Farber Cancer Institute Merrimack Valley, Lawrence, MA
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Knight Cancer Institute, Division of Oncologic Sciences, Oregon Health and Science University, Portland, OR
Haematologica Early view Dec 29, 2022 https://doi.org/10.3324/haematol.2022.281828